Rise and shine. Another shiny day is on the way. And it looks to be a busy one, since we are off the Pharmalot corporate campus today for a series of meetings. Nonetheless, some rituals remain intact - we are about to stop for a mandatory cup of stimulation. Meanwhile, here are some tidbits from around the world. Hope your day goes well...
Former Duane Reade CEO Gets Prison For Inflating Books (Bloomberg News)
Sanofi In Talks To Buy Codliver Oil Business In India (Economic Times)
Will The Pfizer And Bristol Bloodthinner Be A Winner? (Reuters)
Amgen Gets PDUFA Date To Expand Xvega Use (Pharma Times)
Glaxo HPV Vaccine Protects Women From Anal Cancer (Reuters)
UK's NICE Nixes AstraZeneca Breast Cancer Drug (Pharma Times)
MedImmune Sues Abbott Over Drug Development Deal (Washington Business Journal)
Biphosphonates May Lower Colon Cancer Risk (Reuters)
Catalent To Buy Aptuit Clinical Trials Business (Contract Pharma)
Sangart Plans Extra Hiring At Irish Plant (Irish Times)
EDITOR’S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr
2 Comments
WRT to Pfizer and Bristol bloodthinners, I have some questions. Antidote? Who is liable for problems?
I'm sure the prosecutor from Manhattan, who has probably stood on line many times at Duane Reade, couldn't help but smile as he described its CEO's malfeasance as "ongoing" & "continuous."